Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

RxSight (RXST) Return on Equity (2021 - 2025)

RxSight (RXST) has disclosed Return on Equity for 5 consecutive years, with 0.0% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Equity rose 10.0% year-over-year to 0.0%, compared with a TTM value of 0.0% through Dec 2025, up 10.0%, and an annual FY2025 reading of 0.0%, up 12.0% over the prior year.
  • Return on Equity was 0.0% for Q4 2025 at RxSight, up from 0.13% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.51% in Q3 2021 and bottomed at 0.72% in Q4 2022.
  • Average Return on Equity over 5 years is 0.24%, with a median of 0.22% recorded in 2024.
  • The sharpest move saw Return on Equity tumbled -116bps in 2022, then soared 42bps in 2023.
  • Year by year, Return on Equity stood at 0.34% in 2021, then plummeted by -113bps to 0.72% in 2022, then soared by 58bps to 0.3% in 2023, then soared by 67bps to 0.1% in 2024, then surged by 100bps to 0.0% in 2025.
  • Business Quant data shows Return on Equity for RXST at 0.0% in Q4 2025, 0.13% in Q3 2025, and 0.12% in Q2 2025.